Press Releases

Press Releases

Data pager

1 2 3

Show:

PageSizeComboBox
	select

3 pages

10-16-2018

The Phase I/II trial with Remygen^® for the regeneration of insulin-producing cells is recruiting patients

10-3-2018

Year-End Report 17/18

9-18-2018

Diamyd Medical clarifies the goal of applying for earlier market approval for Diamyd^®

9-11-2018

Positive 15-month results with Diamyd^® in Type 1 diabetes

8-23-2018

Diamyd Medical exercises all of its warrants in NextCell Pharma

8-21-2018

Strategic expansion of Diamyd Medical's European Phase II trial in Type 1 diabetes

8-21-2018

Strategic expansion of Diamyd Medical's European Phase II trial in Type 1 diabetes

7-4-2018

The GABA/Diamyd^® trial in the US now fully recruited

6-27-2018

Quarterly Report III 17/18

6-13-2018

Diamyd Medical’s Remygen™ for regeneration of insulin-producing cells approved for clinical trials

© 2016 -

Privacy Policy | Cookie Policy

Share This Page